Mylan (NASDAQ:MYL) will report earnings after markets close on Thursday, May 2nd. Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.
Here is your Cheat Sheet to Mylan Earnings:
Earnings Expectations: Analysts expect earnings of $0.62 per share on revenues of $1.69 billion. Currently, the company’s P/E ratio stands at 19.26.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.66 to a profit $0.69. For the current year, the average estimate is a profit of $2.87, which is better than the estimate ninety days ago.
Here’s how Mylan has been performing on an annual basis:
|Revenue ($) in millions||5,138||5,093||5,451||6,130||6,796|
|Diluted EPS ($)||-1.05||0.30||0.68||1.22||1.52|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||1,531||1,592||1,692||1,810||1,702|
|Diluted EPS ($)||0.3014||0.30||0.33||0.51||0.3925|
Mylan has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)